You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
5 August 2026 - Biopharmaceutical company Citius Oncology Inc (Nasdaq: CTOR), a subsidiary of Citius Pharmaceuticals Inc (Nasdaq: CTXR), on Wednesday reported continued commercial progress for LYMPHIR, with the number of new institutional accounts or...
5 August 2026 - Clinical-stage biopharmaceutical company Obsidian Therapeutics Inc (Nasdaq:OBX) on Wednesday announced enrolment of the first patient in the registration-enabling cohort of its Phase 1/2 Agni-01 study evaluating amsokigene autoleucel ...
5 August 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ: SMMT) reported on Wednesday that it has expanded the global clinical development programme for its investigational bispecific antibody ivonescimab by launching the Ph...
5 August 2026 - Sisram Medical Ltd (HK:1696), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced on Tuesday the official launch of its Titanium Prime treatment concept in Hong Kong S...
4 August 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that it has received European Commission approval to expand the EU indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vacc...
3 August 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) announced on Monday that it has received U.S. Food and Drug Administration Breakthrough Therapy designation for olomorasib as a monotherapy for adults with previously treated advanced...
3 August 2026 - Gene therapy company Genprex Inc (NASDAQ: GNPX) disclosed on Monday that it has entered into a collaboration with Roche Diagnostics to validate biomarkers for patient selection in non-small cell lung cancer (NSCLC) clinical trials, su...